References

No references inside the corpus for this window.

Cited by

• 2012Big Pharma, little science?133 cited
• 2011The impact of mergers on pharmaceutical R&D109 cited
• 2018Financialized Corporations in a National Innovation System: The U.S. Pharmaceutical Industry101 cited
• 2013Access to cancer medications in low- and middle-income countries99 cited
• 2010When R&D spending is not enough: The critical role of culture when you really want to innovate87 cited
• 2014A decade of innovation in pharmaceutical R&D: the Chorus model81 cited
• 2020The endless frontier? The recent increase of R&D productivity in pharmaceuticals77 cited
• 2013Innovation and Marketing in the Pharmaceutical Industry77 cited
• 2013Accelerating commercialization: a new model of strategic foundation funding48 cited
• 2009The case for open‐access chemical biology44 cited
• 2012A co-evolutionary perspective on the drivers of international sourcing of pharmaceutical R&D to India39 cited
• 2020The introduction of research ethics review procedures at a university in South Africa: review outcomes of a social science research ethics committee38 cited
• 2024Technological mediation, mediating morality and moral imaginaries of design: Performance measurement systems in the pharmaceutical industry32 cited
• 2011